Figure 2
From: Current status of sublingual immunotherapy in the United States
6Daily symptom and medication scores with timothy grass sublingual tablet. Daily symptom score (DSS) and daily medication score (DMS) over the entire and peak grass pollen season (GPS). *Medians are reported for DSS, and means are reported for DMS. Between-treatment differences in DSS for MK-7243 vs placebo were -0.64 over the entire GPS and -0.69 over the peak GPS. Between-treatment differences in DMS for MK-7243 vs placebo were -0.48 over the entire GPS and -0.62 over the peak GPS.